RINVOQ 45 mg prolonged-release tablets | medicines.ie

Company: AbbVie Limited
Active Ingredient: Upadacitinib
Strength: Upadacitinib: 45 mg
Dosage Form: Prolonged-release tablet
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/19/1404/0010	45 mg	L04AF03	Prolonged-release tablet

Licence number: EU/1/19/1404/0010
Strength: 45 mg
ATC Code: L04AF03
Dosage Form: Prolonged-release tablet

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland